(Q42947572)
Statements
Bevacizumab combined with two-weekly paclitaxel as first-line therapy for metastatic breast cancer (English)
Panteleimon Kountourakis
Dimitrios Doufexis
Savoula Maliou
Athanasios Karagiannis
Eugenia Kardara
Charalampia Margari
Despoina Sykoutri
Alexandros Tzovaras
Alexandros Ardavanis